News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
3,245 Results
Type
Article (89)
Press Release (3156)
Section
Business (284)
Career Advice (22)
Deals (47)
Drug Development (1910)
FDA (62)
Job Trends (61)
News (2086)
Policy (87)
Tag
Academia (3)
Accelerated approval (1)
Allergies (1)
Alliances (43)
ALS (6)
Alzheimer's disease (19)
Approvals (61)
Artificial intelligence (2)
Autoimmune disease (3)
Best Places to Work (63)
Bladder cancer (4)
Breast cancer (2)
Cancer (35)
Cardiovascular disease (7)
Career advice (17)
CAR-T (2)
Cell therapy (2)
Clinical research (1917)
Collaboration (2)
COVID-19 (18)
C-suite (3)
Cystic fibrosis (4)
Data (209)
Depression (4)
Diabetes (10)
Diagnostics (1)
Drug discovery (3)
Duchenne muscular dystrophy (3)
Earnings (284)
Editorial (1)
Events (450)
FDA (91)
Frontotemporal dementia (1)
Funding (1)
Gene editing (2)
Gene therapy (10)
GLP-1 (13)
Government (6)
Guidances (2)
Healthcare (67)
Immunology and inflammation (4)
Indications (1)
Infectious disease (19)
Inflammatory bowel disease (2)
Influenza (1)
Interviews (7)
IPO (37)
Job creations (1)
Job search strategy (13)
Labor market (1)
Legal (4)
Lung cancer (9)
Lymphoma (1)
MASH (3)
Medical device (19)
Medtech (19)
Mergers & acquisitions (10)
Metabolic disorders (24)
Multiple sclerosis (4)
Neurodegenerative disease (3)
Neuropsychiatric disorders (1)
Neuroscience (41)
NextGen: Class of 2026 (7)
Non-profit (5)
Obesity (11)
Ovarian cancer (1)
Pain (1)
Pancreatic cancer (5)
Parkinson's disease (3)
Patient recruitment (5)
People (19)
Phase 1 (644)
Phase 2 (955)
Phase 3 (526)
Pipeline (70)
Postmarket research (52)
Preclinical (24)
Radiopharmaceuticals (1)
Rare diseases (18)
Real estate (1)
Regulatory (114)
Resumes & cover letters (6)
Rett syndrome (4)
RSV (1)
Schizophrenia (2)
Series B (1)
Sickle cell disease (6)
Spinal muscular atrophy (7)
Sponsored (1)
Vaccines (15)
Weight loss (6)
Date
Last 7 days (5)
Last 30 days (13)
Last 365 days (312)
2026 (21)
2025 (320)
2024 (322)
2023 (320)
2022 (355)
2021 (358)
2020 (250)
2019 (214)
2018 (136)
2017 (174)
2016 (128)
2015 (109)
2014 (91)
2013 (69)
2012 (59)
2011 (58)
2010 (40)
Location
Africa (3)
Asia (287)
Australia (22)
California (124)
Canada (25)
China (26)
Connecticut (5)
Delaware (1)
Europe (409)
Florida (7)
Georgia (8)
Illinois (8)
Indiana (1)
Japan (2)
Maryland (19)
Massachusetts (85)
Minnesota (2)
New Jersey (22)
New York (51)
North Carolina (4)
Northern California (64)
Pennsylvania (42)
South America (2)
Southern California (44)
Tennessee (1)
Texas (15)
United States (397)
Utah (10)
Virginia (1)
Washington D.C. (1)
Washington State (6)
3,245 Results for "saes getters".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Resonetics to Acquire SAES Medical Nitinol Business
Resonetics announced that it has signed an agreement to acquire Memry Corporation and SAES Smart Materials, Inc. from SAES Getters S.p.A, Milan, Italy.
January 9, 2023
·
5 min read
Editorial
Sarepta, Biotech’s Regulatory Go-Getter, Signs Standout Rare Disease Deal
Not exactly known for its dealmaking, Sarepta Therapeutics has thrown down a massive wad of cash to work with Arrowhead Pharmaceuticals on RNAi-based medicines.
December 4, 2024
·
3 min read
·
Annalee Armstrong
Press Releases
Based on Recent FDA Feedback RAPT Therapeutics Stops Zelnecirnon Program Following Clinical Hold Due to Single SAE of Severe Liver Injury
November 11, 2024
·
3 min read
BioMidwest
Neogen, National FFA Announce 2022 Partnership SAE Grant Recipients
Neogen® Corporation announced the recipients of Supervised Agricultural Experience Grants, funded through the Company’s 2022 partnership agreement with the National FFA Foundation.
February 17, 2023
·
4 min read
Press Releases
Ascletis Announces Positive Topline Results from Its Phase III Open-Label Study of Denifanstat (ASC40), a First-in-Class, Once-Daily Oral FASN Inhibitor for Acne
January 29, 2026
·
3 min read
Press Releases
IN8bio Presents Updated Phase I/II Data Demonstrating Meaningful and Durable Survival Improvements in Newly Diagnosed Glioblastoma
January 12, 2026
·
5 min read
Press Releases
Sumitomo Pharma America and Former Professional Quarterback Rodney Peete Say it’s Time to Go™ and Put Yourself First with Overactive Bladder Treatment Option GEMTESA®
June 30, 2025
·
8 min read
Press Releases
Sagimet Announces Positive 52-Week Data from License Partner Ascletis’ Open-Label Phase 3 Clinical Trial Evaluating the Long-Term Safety of ASC40 (Denifanstat) Tablets in Patients with Moderate to Severe Acne
February 2, 2026
·
8 min read
Press Releases
NTT Scientists Contribute Fifteen Research Papers to NeurIPS 2025
December 4, 2025
·
8 min read
Press Releases
Valneva Provides Update on Chikungunya Vaccine IXCHIQ®
January 20, 2026
·
6 min read
1 of 325
Next
